<DOC>
	<DOCNO>NCT01711827</DOCNO>
	<brief_summary>The purpose study assess effect multiple dose isavuconazole pharmacokinetics prednisolone single dose administration prednisone . This study also assess safety tolerability isavuconazole alone combination prednisone .</brief_summary>
	<brief_title>A Study Evaluate Effect Multiple Doses Isavuconazole Pharmacokinetics Single Dose Prednisone Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<criteria>The subject body weight least 45 kg body mass index ( BMI ) 18 32 kg/m2 , inclusive Results aspartate aminotransferase ( ALT ) must ≤ upper limit normal total bilirubin must ≤ 1.5 mg/dL The female subject agree sexual abstinence , surgically sterile , postmenopausal ( define least 2 year Screening without menses ) , use medically acceptable double barrier method ( e.g . spermicide diaphragm , spermicide condom ) prevent pregnancy agree continue use method Screening 3 week followup visit end study ; lactate pregnant document negative pregnancy test Screening Day 1 The male subject agree sexual abstinence , surgically sterile , use medically acceptable method prevent pregnancy agree continue use method Screening 3 week followup visit end study The subject history unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia torsade de pointes , structural heart disease , family history Long QT syndrome ( suggest sudden death close relative young age due possible probably cardiac cause The subject history tuberculosis exposure anyone know suspected tuberculosis illness might confound result study pose additional risk administer study drug subject The subject positive result hepatitis C antibody , hepatitis B surface antigen , QuantiFERON®TB Gold test Screening know positive human immunodeficiency virus ( HIV ) The subject know suspect allergy component trial product include prednisone azole class compound , history multiple and/or severe allergy drug food history severe anaphylactic reaction The subject smoker ( use tobacco nicotine containing product ) within 6 month prior Screening The subject treatment prescription drug complementary alternative medicine within 14 day prior Day 1 , overthecounter medication within 1 week prior Day 1 , exception acetaminophen 2 g/day The subject recent history ( within last 2 year ) drug alcohol abuse positive drug and/or alcohol screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>isavuconazole</keyword>
	<keyword>prednisone</keyword>
	<keyword>prednisolone</keyword>
	<keyword>BAL8557</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>